Filler Use Shifts Toward Structural Preservation and Long-Term Aesthetic Planning

Concerns about “filler fatigue” are reshaping aesthetic dermatology, but demand for fillers remains strong when treatments prioritize natural movement, structural balance, and long-term facial preservation, according to Doris Day, MD, FAAD, during her session, “Why Fillers Are Filling My Practice​,” presented at Music City SCALE 2026.

Dr Day described a changing patient mindset in which exaggerated or overfilled outcomes have increased caution around injectables. However, she emphasized that the decline is not due to reduced interest in fillers themselves. “Decline in fillers is due to unnatural outcomes, not lack of demand,” she stated.

Rather than focusing on isolated line correction, current strategies increasingly emphasize holistic facial assessment and gradual restoration. Aging-related changes, including bone resorption, fat loss, muscle changes, skin laxity, and hormonal transitions, must all be considered during treatment planning.

Dr Day stressed that fillers should be used to “restore support” rather than simply “fill lines.” This requires careful product selection, strategic placement, and understanding of longitudinal facial aging patterns. Considerations such as genetic predisposition and menopausal changes were also highlighted as contributors to facial structural decline.

She advocated for a “layered, precise, longitudinal approach” grounded in full-face assessment. Balance should be prioritized over strict symmetry, with treatments designed to preserve expression and maintain identity. Dr Day remarked that aesthetic care should focus on helping patients “look refreshed” while ensuring the preservation of natural movement.

Combination therapy is central to modern filler practice. Injectable treatments are increasingly paired with energy-based devices, skincare, growth factors, and biostimulatory agents to address multiple layers of aging simultaneously. Pre-treatment optimization strategies include hydration, sun protection, selective mTORC1 inhibitors, and exosome-based approaches.

Filler selection itself has become more nuanced, with consideration of rheology and distinctions between hyaluronic acid fillers, biostimulators, and permanent fillers. Dr Day noted that treatment decisions should align with long-term structural goals rather than immediate volumization alone.

Patient communication is also essential. Dr Day suggested that clinicians should create realistic timelines and avoid assumptions about budget or treatment priorities. Starting with smaller, staged treatments may improve trust and support more natural outcomes over time.

She concluded that “combination therapy is greater than standalone filler” and encouraged clinicians to “design for decades,” emphasizing maintenance and longevity over short-term correction.

For more meeting coverage, visit the Music City SCALE newsroom.

Reference
Day D. Why fillers are filling my practice. Presented at: Music City SCALE Symposium; May 13–17, 2026; Nashville, TN.